10.42
price up icon0.10%   0.010
after-market Dopo l'orario di chiusura: 10.44 0.02 +0.19%
loading

Viatris Inc Borsa (VTRS) Ultime notizie

pulisher
03:31 AM

Chart based analysis of Viatris Inc. trendsGap Down & Expert Approved Trade Ideas - Newser

03:31 AM
pulisher
02:31 AM

Intraday pattern recognizer results for Viatris Inc.July 2025 Decliners & Fast Gaining Stock Strategy Reports - Newser

02:31 AM
pulisher
07:20 AM

How to use a screener to detect Viatris Inc. breakouts2025 Market WrapUp & High Accuracy Swing Entry Alerts - Newser

07:20 AM
pulisher
06:48 AM

What high frequency data says about Viatris Inc.2025 Trading Volume Trends & Daily Growth Stock Investment Tips - Newser

06:48 AM
pulisher
Aug 26, 2025

Market reaction to Viatris Inc.’s recent newsWeekly Profit Analysis & Real-Time Sentiment Analysis - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Key resistance and support levels for Viatris Inc.July 2025 Fed Impact & Daily Chart Pattern Signal Reports - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Using data models to predict Viatris Inc. stock movementJuly 2025 Momentum & Short-Term Swing Trade Alerts - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Advanced analytics toolkit walkthrough for Viatris Inc.Market Activity Summary & Safe Entry Point Alerts - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Stock Analysis | Viatris OutlookA Stock at a Crossroads Between Weak Technicals and Mixed Fundamentals - AInvest

Aug 26, 2025
pulisher
Aug 26, 2025

Full technical analysis of Viatris Inc. stockEarnings Trend Report & Trade Opportunity Analysis Reports - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Should you hold or exit Viatris Inc. nowWeekly Profit Report & Advanced Swing Trade Entry Alerts - Newser

Aug 26, 2025
pulisher
Aug 25, 2025

What moving averages say about Viatris Inc.Market Movement Recap & Risk Controlled Stock Alerts - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

Viatris Inc. shares fall 1.13% intraday as Theravance Biopharma completes enrollment in pivotal Phase 3 trial. - AInvest

Aug 25, 2025
pulisher
Aug 25, 2025

Saudi Arabia Generic Drugs Market Outlook and Company Analysis 2025-2033 Featuring Teva, Viatris, Sa - PharmiWeb.com

Aug 25, 2025
pulisher
Aug 25, 2025

Viatris Inc. (VTRS) Stock Analysis: Navigating a 7.31% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews

Aug 25, 2025
pulisher
Aug 23, 2025

How to track smart money flows in Viatris Inc.Portfolio Update Report & Weekly Breakout Opportunity Watchlist - Newser

Aug 23, 2025
pulisher
Aug 23, 2025

How to build a dashboard for Viatris Inc. stockJuly 2025 Summary & Comprehensive Market Scan Reports - Newser

Aug 23, 2025
pulisher
Aug 20, 2025

Viatris' Strategic Leadership Realignment and Long-Term Growth Potential - AInvest

Aug 20, 2025
pulisher
Aug 20, 2025

Ex-Dividend Reminder: Evergy, Viatris and CRH - Nasdaq

Aug 20, 2025
pulisher
Aug 19, 2025

Q2 Earnings Roundup: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Segment - FinancialContent

Aug 19, 2025
pulisher
Aug 19, 2025

Viatris Inc. Appoints Andrew Enrietti as Chief Administrative and Transformation Officer - MarketScreener

Aug 19, 2025
pulisher
Aug 19, 2025

Night Vision Disturbances Market to Experience Notable Growth by 2034, DelveInsight Predicts | Ocuphire Pharma, Viatris - The Globe and Mail

Aug 19, 2025
pulisher
Aug 19, 2025

Lead Plaintiff Appointed in Viatris Class Action — Here’s How You Can Recover Your Losses - TradingView

Aug 19, 2025
pulisher
Aug 19, 2025

Viatris names Andrew Enrietti as chief administrative officer - Investing.com

Aug 19, 2025
pulisher
Aug 19, 2025

Viatris Appoints Andrew Enrietti as Chief Administrative and Transformation Officer - Viatris

Aug 19, 2025
pulisher
Aug 19, 2025

Global Healthcare Giant Viatris Creates New C-Suite Role to Drive Digital Transformation Strategy - Stock Titan

Aug 19, 2025
pulisher
Aug 19, 2025

Viatris Inc. shares fall 1.79% premarket after Jefferies adjusted price target to $14. - AInvest

Aug 19, 2025
pulisher
Aug 18, 2025

Viatris Inc Faces Headwinds: Diminished Financial Strength, Growth, and Valuation Rankings - AInvest

Aug 18, 2025
pulisher
Aug 18, 2025

Jefferies Adjusts Price Target on Viatris to $14 From $13, Maintains Buy Rating - MarketScreener

Aug 18, 2025
pulisher
Aug 15, 2025

What are the risks of holding Viatris Inc.Weekly Stock Summary & Stock Market Timing Techniques - classian.co.kr

Aug 15, 2025
pulisher
Aug 15, 2025

Viatris Inc. Consolidation Zone May Signal Accumulation2025 Market WrapUp & High Conviction Investment Ideas - newsyoung.net

Aug 15, 2025
pulisher
Aug 14, 2025

David Einhorn's Greenlight Capital Boosts Fluor Corp, Exits Viatris, Peloton, and Kyndryl - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Trump EO to bolster stockpile of active pharmaceutical ingredients for drugs - Seeking Alpha

Aug 14, 2025
pulisher
Aug 14, 2025

5 Must-Read Analyst Questions From Viatris’s Q2 Earnings Call - Yahoo Finance

Aug 14, 2025
pulisher
Aug 14, 2025

Viatris Signals Ongoing Strategic Overhaul, Promises Update In Q3 - insights.citeline.com

Aug 14, 2025
pulisher
Aug 14, 2025

Saudi Arabia Generic Drugs Market Outlook Report 2025-2033 | Government Cost-Cutting, Local Manufacturing, and Public Awareness Fuel Rapid Growth - GlobeNewswire Inc.

Aug 14, 2025
pulisher
Aug 14, 2025

Day 5 of Gains Streak for Viatris Stock with 19% Return (vs. -14% YTD) [8/13/2025] - Trefis

Aug 14, 2025
pulisher
Aug 13, 2025

CEO Makes Bold Move with Major Viatris Stock Purchase - TipRanks

Aug 13, 2025
pulisher
Aug 13, 2025

Viatris CEO Smith buys $219k in company stock By Investing.com - Investing.com Nigeria

Aug 13, 2025
pulisher
Aug 13, 2025

Viatris CEO Smith buys $219k in company stock - Investing.com India

Aug 13, 2025
pulisher
Aug 13, 2025

Viatris CEO Smith Buys 22K Shares at $9.99/Share on August 12, 2023. - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

Avantor, Viatris, and Amneal Stocks Trade Up, What You Need To Know - Yahoo Finance

Aug 13, 2025
pulisher
Aug 13, 2025

VTRS Q2 Deep Dive: Pipeline Progress and Cost Discipline Drive Results Amid Industry Headwinds - ca.finance.yahoo.com

Aug 13, 2025
pulisher
Aug 12, 2025

Bruker, Viatris, Sotera Health Company, Align Technology, and Omnicell Stocks Trade Up, What You Need To Know - Yahoo Finance

Aug 12, 2025
pulisher
Aug 12, 2025

Viatris first to win US approval for generic Venofer - The Pharma Letter

Aug 12, 2025
pulisher
Aug 12, 2025

Brufen Maker Viatris Fails To Halt Rival's 'Brisen' TM Quest - Law360

Aug 12, 2025
pulisher
Aug 12, 2025

Iron Sucrose Competition Expands With Viatris and Amphastar FDA Approvals - insights.citeline.com

Aug 12, 2025
pulisher
Aug 12, 2025

Viatris wins FDA nod for generic iron sucrose injection targeting Daiichi’s Venofer - MSN

Aug 12, 2025
pulisher
Aug 12, 2025

Viatris Announces Approval of First Generic Iron Sucrose Injection in the U.S. - BioSpace

Aug 12, 2025
pulisher
Aug 12, 2025

Why Viatris (VTRS) Is Up 10.3% After Beating Q2 Estimates and Securing FDA Generic Win - simplywall.st

Aug 12, 2025
pulisher
Aug 11, 2025

Ampicillin Market Driven by Rising Bacterial Infections - openPR.com

Aug 11, 2025
pulisher
Aug 11, 2025

Sector Update: Health Care - MarketScreener

Aug 11, 2025
drug_manufacturers_specialty_generic RDY
$14.24
price up icon 0.21%
$138.13
price up icon 0.94%
$305.35
price down icon 1.25%
$18.49
price up icon 3.30%
$29.25
price up icon 0.93%
Capitalizzazione:     |  Volume (24 ore):